NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 31, 2024 — Telomir Pharmaceuticals Inc. is leading the way in anti-aging research with its potential treatment Telomir-1, aiming to reverse age-related conditions and extend lifespans. With positive preclinical studies and a massive market opportunity, this breakthrough could have a significant impact on human and pet health.
May 30, 2024 — Discover the importance of gut health and how MyFitnessPal's Gut Health Nutrition Plan, in collaboration with experts like Maya Feller and Dr. Janese Laster, can transform your well-being. Improve your focus, energy, mood, sleep, and weight through better eating habits and valuable resources.
May 30, 2024 — PaxMedica prepares to submit NDA for suramin to treat Human African Trypanosomiasis, a significant step forward in addressing the disease. Learn more about the company's progress and its upcoming Type C meeting with the FDA.
May 30, 2024 — Immunic Inc CEO Daniel Vitt discusses the challenges and recent developments in treating multiple sclerosis (MS), emphasizing the unmet medical need for effective treatments and highlighting the potential of vidofludimus calcium to transform MS treatment.
May 30, 2024 — Cure Alzheimer’s Fund recognizes David M. Holtzman, M.D., and Xiaoying Chen, Ph.D. with the inaugural Morby Prize for their groundbreaking research on Alzheimer’s disease. The prize, named after the late Co-Founder of Cure Alzheimer’s Fund, aims to advance the fundamental understanding of the disease and translate scientific results into effective ways to prevent, diagnose, or treat Alzheimer’s.
May 30, 2024 — Medical malpractice lawsuit filed against Restorative Pain Institute in Louisville due to nurse's theft of patients' pain medication. Victims encouraged to seek justice and compensation. McCoy & Hiestand offers guidance and support.
May 29, 2024 — Clene (CLNN) announces key updates on NIH-funded Expanded Access Program for CNM-Au8 compassionate use in ALS, highlighting the potential impact of the investigational drug in treating neurodegenerative diseases.
May 29, 2024 — PathAI introduces PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™, cutting-edge AI products for cancer research and treatment. These innovative solutions offer unprecedented insights into treatment response and biomarker discovery, driving advancements in patient care and survival rates.
May 29, 2024 — Global Retinoblastoma Treatment Market, Iovance Biotherapeutics FDA Approval, Necroptosis Therapies, Oncotelic Therapeutics, Mosaic ImmunoEngineering
May 29, 2024 — hyperCORE International expands its global reach by welcoming Applied Research Center of Arkansas to its clinical trial network. Dr. Nathan Livers, CEO of ARC, brings a passion for clinical research and patient care, making the decision to join hyperCORE an easy one.
May 29, 2024 — Dr. Quodarrius Toney (Dr. Q) honored with America's Best Dentist Award for 2024, showcasing his dedication to excellence in cosmetic dentistry and commitment to personalized patient care.
May 28, 2024 — AuditSoft partners with Site App Pro to streamline workplace safety and improve compliance. This collaboration reflects a joint commitment to digital transformation in the safety industry, aiming to make life easier for safety professionals and organizations.
May 28, 2024 — Clene (NASDAQ: CLNN) presents CNM-Au8(R) at investor conferences, showcasing its potential for treating neurodegenerative diseases. Learn more about Clene's participation and the development of CNM-Au8(R).
May 28, 2024 — PaxMedica (NASDAQ: PXMD) receives urgent plea from Malawi Ministry of Health for emergency access to IV suramin, highlighting the potential impact of pharmaceutical companies on global health crises.
May 28, 2024 — Voyageur Pharmaceuticals CEO Brent Willis signs a significant sales contract for the Latin American market, marking a milestone for the company and positioning it for growth and expansion.
May 28, 2024 — Cardiol Therapeutics (NASDAQ:CRDL) (TSX:CRDL) is gaining investor interest with the potential for further upside, driven by the upcoming topline data release for its Phase 2 clinical trial. The news highlights the growth prospects and investment opportunities in the biotech sector.
May 27, 2024 — Compumedics Ltd's CFO discusses the company’s projected record revenues of $46 million for FY24, driven by strong growth in its sleep and neurodiagnostic businesses and increased European sales. The company also expects SaaS revenue to exceed $4 million for FY24.
May 25, 2024 — Blue Ridge Therapeutic Wilderness: Nature-based therapy program for adolescent technology addiction
May 24, 2024 — Oncimmune CEO announces robust interim results and revenue growth, demonstrating strategic shift and commercial momentum, positioning the company for continued growth.
May 24, 2024 — Raw Juicery announces the launch of a new line of organic juice cleanses designed to support detoxification and overall health improvement. The collection includes a variety of juice cleanses tailored to meet different health needs and goals. The company's founder emphasizes the importance of preparation for a cleanse, advising customers to adopt a balanced diet and increase hydration before starting any cleanse.